UTUC
Advertisement
CME Content
Advertisement
Please check back later for more content.
Advertisement
Advertisement
Trending on Urology Times
1
Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026
2
LITESPARK-012: Lessons from a negative phase 3 trial in first-line RCC
3
ESMO 2026 recap: Notable updates across genitourinary oncology
4
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
5


